The Convergys®
POC RT-PCR COVID-19 Testing Platform
- Point-of-care
- Workplace setting
Our Testing Platform integrates WHO endorsed RT-PCR methodology into a convenient and easy-to-use format. The pre-filled, single-use cartridges take care of the complete patient sample processing, including RNA extraction, purification and RT-PCR amplification; all within 90 minutes.
The Convergys® POC RT-PCR COVID-19 Testing Platform directly detects SARS-CoV-2 genetic material.
Features
Qualitative detection of the novel coronavirus SARS-CoV-2
Real-time PCR methodology
Targets specific nucleotide sequences of SARS-CoV-2
Cartridge based kit for the use with the Convergys® POC RT-PCR system
Result within 90 minutes
Internal control material for validation of results
The Convergys® POC RT-PCR system is fully automated:
- Easy operation
- Reduced hands-on time
- Reduced exposure to infectious material
- Reduced risk of application errors
Direct application of sample material, no previous extraction is required
Workflow
Time Saving:
- 2 minutes sample preparation
- 90 minutes to result
- 10 minutes for training of medical staff
Validation & Active Installations
At the outset of the Pandemic, we successfully validated the Testing Platform in the field at Institute of Microbiology and Epidemiology of the
Academy of Military Medicine of China and State Key Laboratory of
Pathogen and Biosecurity, The Academy of Millitary Medical Science,
Institute of Microbiology and Epidemiology, Beijing, PRC.
Starting with the launch in March 2020 of Convergys® POC RT-PCR, a fully-integrated system from the viral RNA extraction to onsite reference and central lab-grade results in real-time, Convergent has been a trusted partner in quick and reliable patient triage, isolation and therapy management solutions. Thousands of these tests were successfully deployed in many clinical and corporate settings.
And fast-forward to June 2021, the systems are currently in active use at CDCs, University Research Institutes, Clinics, Tourism Organizations, National Defence, Critical Support Infrastructures and NGOs in EU and in many other geographies worldwide.
Starting with the launch in March 2020 of Convergys® POC RT-PCR, a fully-integrated system from the viral RNA extraction to onsite reference and central lab-grade results in real-time, Convergent has been a trusted partner in quick and reliable patient triage, isolation and therapy management solutions. Thousands of these tests were successfully deployed in many clinical and corporate settings.
And fast-forward to June 2021, the systems are currently in active use at CDCs, University Research Institutes, Clinics, Tourism Organizations, National Defence, Critical Support Infrastructures and NGOs in EU and in many other geographies worldwide.
Specifications
Convergys® POC RT-PCR COVID-19 Test Cartridge
Convergys® POC RT-PCR System Device
Intended Use:
Detection of SARS-CoV-2
For Use With:
Convergys® POC RT-PCR System
Target Sequences:
SARS-CoV-2 S Gene & N Gene
Storage Condition:
2 - 8°C
Shelf Life:
6 months
Package Contents:
24 Test Cartridges; 240 µl Magnetic Beads
Sample Volume / Test:
200 µl
Detection Principle:
Multiplex PCR, up to 5 Channels
Sample capacity:
4 independent samples
Block Temperature:
40 - 99°C
Fluorochrome/dye (Channel 1):
FAM, SYBRGreen I
Fluorochrome/dye (Channel 2):
HEX,VIC
Fluorochrome/dye (Channel 3):
TAMRA,CY3
Fluorochrome/dye (Channel 4):
TEX RED,ROX
Fluorochrome/dye (Channel 5):
CY5
Fluorescence detection time:
≤ 5s
Connectivity:
USB, Wi-Fi
User interface:
7” Color touch screen
Working conditions:
5 - 35°C; 0 - 70% RH; 0 - 3999 m altitude
Power requirement:
AC100 - 240V, 50 - 60Hz
Dimensions and weight:
380 x 305 x 343 mm, 16 kg